Norvasc
These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1987
Approved
Approval ID
b00570ff-4081-4514-b45b-eb6f753450f5
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 28, 2010
Manufacturers
FDA
Rebel Distributors Corp
DUNS: 118802834
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
amlodipine besylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code21695-151
Application NumberNDA019787
Product Classification
M
Marketing Category
C73594
G
Generic Name
amlodipine besylate
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 20, 2010
FDA Product Classification
INGREDIENTS (5)
amlodipine besylateActive
Quantity: 5 mg in 1 1
Code: 864V2Q084H
Classification: ACTIM
cellulose, microcrystallineInactive
Code: OP1R32D61U
Classification: IACT
anhydrous dibasic calcium phosphateInactive
Code: L11K75P92J
Classification: IACT
sodium starch glycolate type A potatoInactive
Code: 5856J3G2A2
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT